Our Pipeline

Fusce massa odio, lacinia id leo at, eleifend egestas nibh. Etiam placerat magna sit amet scelerisque pulvinar. Quisque tempor ex nulla. Nullam non aliquam mauris, nec semper velit. Duis aliquam fermentum sem quis fermentum. Nunc at nunc vitae sem tempor vestibulum. Sed commodo a tortor placerat lacinia. Mauris placerat tempor nibh, lobortis imperdiet mauris egestas nec.
Quisque tincidunt ex non lacus finibus euismod. Praesent congue turpis a pulvinar varius. Etiam tempor sapien in viverra tincidunt. Quisque tempor ex nulla. Nullam non aliquam mauris, nec semper velit. Duis aliquam fermentum.

Our Discovery Platform is Delivering

Lorem ipsum dolor sit ameteur etur ser scing creamer elit. Maec terem bier kem terdum breci bore uismo. Dolor sit ameteur etur ser scing creamer elit.

Discovery Programs

3 Research programs.
Step 1

Drug Targets

3 drug target opportunities.
Step 1

Hit Confirmation

15 compounds in hit confirmation and mode of action evaluation.
Step 1

Screening

Screening of 75000 compound collection with image-based multiparameter readout analysis.
Step 1

Assays

High throughput human oligodendrocyte differentiation assay development.
Step 1

Building a Pipeline

Describing your product, service, or whatever you provide the public with is vitally important, so your copy should include full details. Lorem ipsum dolor sit ameteur etur ser.
High Priority Targets
Validation and Targeting
Hit target class:
1 & 4: epigenetic enzymes | 2: nuclear hormone receptor | 3: chaperon receptor | 5: oxidase
Multiple novel hits with differing pharmacology across several target classes identified from non proprietary compound libraries.
High priority targets being evaluated for in licensable assets.
Multiple novel hits identified from proprietary CNS friendly compound library.
High priority hits being evaluated for validation and target deconvolution.

Our Competitive Advantage

Lorem ipsum dolor sit ameteur etur ser scing creamer elit. Maec terem bier kem terdum breci bore uismo. Dolor sit ameteur etur ser scing creamer elit.
01
Human Led
Human system led discovery
approach.
02
Rapid Expertise
Expertise for rapid translation to clinical development.
03
Multiple Programs
Differentiated discovery
programs.

Find out more about us

Find out more about Pheno Therapeutics and the ground breaking work we do.

Pheno Therapeutics

Based in Edinburgh and positioned to deploy the University’s world-leading expertise in phenotypic screening, stem cell technology and myelin biology, we aim to discover and develop small molecule therapeutics that promote remyelination for the treatment of multiple sclerosis.
Copyright © 2024 All Rights Reserved
| Made by FDM Digital with ❤️
crossmenu